Your browser doesn't support javascript.
loading
Phase II trial of capecitabine and oxaliplatin in patients with adeno- and undifferentiated carcinoma of unknown primary.
Schuette, Katharina; Folprecht, Gunnar; Kretzschmar, Albrecht; Link, Hartmut; Koehne, Claus-Henning; Gruenwald, Viktor; Stahl, Michael; Huebner, Gerdt.
Affiliation
  • Schuette K; University Hospital Carl Gustav Carus, Dresden, Germany. Katharina.Schuette@uniklinikum-dresden.de
Onkologie ; 32(4): 162-6, 2009 Apr.
Article in En | MEDLINE | ID: mdl-19372710
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / Neoplasms, Unknown Primary / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Deoxycytidine / Fluorouracil Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Onkologie Year: 2009 Document type: Article Affiliation country: Alemania Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / Neoplasms, Unknown Primary / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Deoxycytidine / Fluorouracil Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Onkologie Year: 2009 Document type: Article Affiliation country: Alemania Country of publication: Suiza